Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians

Benefits and risks of SGLT2 inhibitor use.[Image: see text]

Detalles Bibliográficos
Autores principales: Fujita, Yoshihito, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
JDI Updates
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825932/
https://www.ncbi.nlm.nih.gov/pubmed/31541588
http://dx.doi.org/10.1111/jdi.13150
_version_ 1783464979257622528
author Fujita, Yoshihito
Inagaki, Nobuya
author_facet Fujita, Yoshihito
Inagaki, Nobuya
author_sort Fujita, Yoshihito
collection PubMed
description Benefits and risks of SGLT2 inhibitor use.[Image: see text]
format Online
Article
Text
id pubmed-6825932
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68259322019-11-07 Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians Fujita, Yoshihito Inagaki, Nobuya J Diabetes Investig JDI Updates Benefits and risks of SGLT2 inhibitor use.[Image: see text] John Wiley and Sons Inc. 2019-10-14 2019-11 /pmc/articles/PMC6825932/ /pubmed/31541588 http://dx.doi.org/10.1111/jdi.13150 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle JDI Updates
Fujita, Yoshihito
Inagaki, Nobuya
Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
title Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
title_full Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
title_fullStr Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
title_full_unstemmed Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
title_short Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
title_sort update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in asians and non‐asians
topic JDI Updates
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825932/
https://www.ncbi.nlm.nih.gov/pubmed/31541588
http://dx.doi.org/10.1111/jdi.13150
work_keys_str_mv AT fujitayoshihito updateontheefficacyandsafetyofsodiumglucosecotransporter2inhibitorsinasiansandnonasians
AT inagakinobuya updateontheefficacyandsafetyofsodiumglucosecotransporter2inhibitorsinasiansandnonasians

Ejemplares similares